Levomac Oral Solution contains Levofloxacin 125 mg per dose, a broad-spectrum fluoroquinolone antibiotic effective against a wide range of Gram-positive and Gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and certain types of gastrointestinal infections. Levofloxacin exerts its bactericidal action by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication, transcription, repair, and recombination, thereby preventing bacterial cell division and leading to cell death. Levomac Oral Solution offers the advantage of easy administration and rapid absorption, with high bioavailability ensuring effective plasma concentrations. It is suitable for patients who require oral antibiotic therapy and may be preferred in cases where intravenous administration is not feasible. Dosage and duration of treatment should be determined based on the type and severity of infection, patient age, renal function, and clinical response. Caution is advised in patients with a history of hypersensitivity to fluoroquinolones, and potential side effects include gastrointestinal disturbances, central nervous system effects, and tendinopathy. Use during pregnancy and lactation should be avoided unless clearly necessary. Levomac Oral Solution should be used in accordance with local antimicrobial stewardship guidelines to minimize resistance development.